--- title: Buy Nocdurna (Desmopressin) 0.2mg Tabs Online description: Nocdurna (Desmopressin) 0.2mg tablets reduce nighttime urination in adults. Order from our secure pharmacy for quality product and reliable shipping. type: product language: en url: https://liabilis.com/order-nocdurna-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 164.99 price_max: 879.99 currency: USD offers: - name: 0.2mg x 30 tabs price: 164.99 - name: 0.2mg x 60 tabs price: 305.99 - name: 0.2mg x 90 tabs price: 449.99 - name: 0.2mg x 120 tabs price: 591.99 - name: 0.2mg x 180 tabs price: 879.99 --- # Buy Nocdurna (Desmopressin) 0.2mg Tabs Online Nocdurna, with Desmopressin, is a sublingual tablet for nocturnal polyuria, reducing nighttime voids in adults. It mimics antidiuretic hormone to concentrate urine overnight. Ideal for patients with nocturia symptoms. Available as 0.2mg tabs from our online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **0.2mg** | 30 tabs | **$164.99** | $5.50 | In Stock | | **0.2mg** | 60 tabs | **$305.99** | $5.10 | In Stock | | **0.2mg** | 90 tabs | **$449.99** | $5.00 | In Stock | | **0.2mg** | 120 tabs | **$591.99** | $4.93 | In Stock | | **0.2mg** | 180 tabs | **$879.99** | $4.89 | In Stock | [Buy Now](https://liabilis.com/order-nocdurna-online-en.html) ## Introduction Nocdurna is a generic tablet that contains the synthetic vasopressin analog desmopressin (0.2 mg). It belongs to the class of antidiuretic hormones and is used primarily to manage central diabetes insipidus, nocturnal enuresis, and certain bleeding disorders such as mild hemophilia A and von Willebrand disease. The medication is taken orally and is formulated for once-daily or twice-daily dosing, depending on the condition treated. ## Quick Reference Facts **Active Ingredient** : Desmopressin **Form** : tablet 0.2 mg **Primary and Off-Label Uses** : • Treatment of central diabetes insipidus : • Management of nocturnal enuresis in children and adolescents : • Control of bleeding in mild hemophilia A and von Willebrand disease : • Off-label: nocturnal polyuria in adults, adjunctive therapy for certain surgical bleeding ## What is Nocdurna? Nocdurna is the generic version of medications containing the active compound desmopressin. Desmopressin is a synthetic analogue of the natural hormone arginine-vasopressin (AVP) that selectively stimulates V2 receptors in the renal collecting ducts, promoting water reabsorption. As a generic product, Nocdurna is marketed under the same therapeutic profile as brand-name formulations such as DDAVP® and Minirin®. These branded versions are often referenced in clinical guidelines, and the availability of Nocdurna provides a cost-effective alternative with equivalent bioavailability. The tablet is manufactured by an internationally recognized pharmaceutical company that complies with Good Manufacturing Practice (GMP) standards, though the specific manufacturer is not disclosed in publicly available sources. ## How Nocdurna Works Desmopressin mimics the action of AVP by binding to V2 receptors on the basolateral membrane of renal collecting-duct cells. This activation triggers a cascade involving cyclic AMP, which promotes the insertion of aquaporin-2 water channels into the apical membrane. The result is increased water permeability, allowing the kidneys to reabsorb free water and concentrate urine. In patients with central diabetes insipidus, deficient endogenous AVP leads to excessive dilute urine; desmopressin restores the antidiuretic effect, reducing polyuria and polydipsia. For nocturnal enuresis, the same mechanism reduces nighttime urine production, helping children achieve dry nights. In bleeding disorders, desmopressin stimulates the release of stored factor VIII and von Willebrand factor from endothelial cells, temporarily raising plasma levels and improving hemostasis. The tablet is rapidly absorbed, with peak plasma concentrations occurring within 1-2 hours. Renal excretion accounts for most of the clearance, and the drug’s half-life is roughly 2-3 hours in healthy adults, allowing flexible dosing schedules. ## Conditions Treated with Nocdurna - **Central Diabetes Insipidus** Desmopressin replaces the missing antidiuretic hormone, decreasing urine output and alleviating excessive thirst. - **Nocturnal Enuresis (Bed-wetting)** By reducing nighttime urine volume, the medication helps children and adolescents achieve sustained dryness, improving sleep quality and self-esteem. - **Mild Hemophilia A** A single dose raises factor VIII levels by 2-3 fold for up to 8 hours, providing temporary bleeding control for minor procedures or breakthrough bleeds. - **Von Willebrand Disease (Type 1)** Desmopressin enhances circulating von Willebrand factor, reducing bleeding time and supporting hemostasis during dental work or minor surgery. Each indication is supported by regulatory approval in multiple jurisdictions, including the United States (FDA) and the European Medicines Agency (EMA). ## Is Nocdurna the Right Medication for You? Nocdurna is appropriate for adults and children (≥6 years) who have a confirmed diagnosis of central diabetes insipidus, nocturnal enuresis, or the specified mild bleeding disorders. It is especially useful when patients require a predictable, oral regimen rather than intranasal or injectable formulations. Patients with severe renal impairment, uncontrolled hyponatremia, or a known hypersensitivity to desmopressin should avoid the medication. Caution is advised in individuals prone to fluid overload, such as those with congestive heart failure or chronic lung disease, because excessive water retention can lead to hyponatremia. Therapeutic decisions should be guided by laboratory values (serum sodium, urine osmolality) and clinical response. If the desired effect is not achieved, dosage adjustments or alternative therapies may be necessary under professional supervision. ## Buying Nocdurna from [our online pharmacy](https://liabilis.com/order-nocdurna-online-en.html) ### Why Choose Our Service? [our online pharmacy](https://liabilis.com/order-nocdurna-online-en.html) offers a convenient, discreet way to obtain Nocdurna when local pharmacies experience shortages or high out-of-pocket costs. By sourcing the medication through verified international partners, we help patients maintain uninterrupted therapy. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of Nocdurna undergoes independent testing for potency, purity, and compliance with regulatory standards before it reaches you. ### Pricing & Access Because Nocdurna is a generic formulation, its price is typically 30 %-50 % lower than brand-name equivalents such as DDAVP® or Minirin®. Our pharmacy service provides transparent pricing, helping you avoid unexpected mark-ups. ### Discreet Delivery Orders are shipped in unmarked packaging, protecting your privacy. With express delivery usually within 7 days-or standard airmail in approximately 3 weeks-your medication arrives quickly and securely through our platform. ## Use: Dosing, Missed Dose, Overdose - **Standard Dosing** • Diabetes insipidus: 0.2 mg tablet once daily, with the possibility of a second evening dose if required. • Nocturnal enuresis: 0.2 mg tablet taken once daily, preferably 30 minutes before bedtime. • Hemophilia A / von Willebrand disease: 0.2 mg tablet administered 30 minutes before the procedure; repeat dosing may be required for prolonged surgeries. - **Missed Dose** If you forget a dose, take it as soon as you remember **provided it is at least 4 hours before the next scheduled dose**. Otherwise, skip the missed dose and resume your regular schedule. Do not double-dose. - **Overdose** Symptoms may include severe hyponatremia, nausea, headache, seizures, or fluid retention. Seek emergency medical care immediately. Contact your local poison control center and inform them that desmorphine was taken in excess. - **Practical Precautions** • Take the tablet with a full glass of water; food does not significantly affect absorption. • Limit excessive fluid intake while on therapy to reduce the risk of hyponatremia. • Avoid alcohol, as it can potentiate water intoxication. • Do not operate heavy machinery if you feel dizzy or confused. ## Safety Information ### ⚠️ Who Should Not Take Nocdurna - Individuals with known hypersensitivity to desmopressin or any tablet excipients. - Patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²). - Those with uncontrolled hyponatremia (serum sodium < 130 mmol/L). - Persons with a history of acute water intoxication or uncontrolled heart failure. ### Common Side Effects - Headache (mild, transient) - Nasal congestion (rare with oral formulation) - Mild gastrointestinal discomfort (nausea, abdominal cramps) These effects are generally self-limiting and do not require medical intervention unless they persist. ### Serious Side Effects (Seek Immediate Medical Help) - Severe hyponatremia (confusion, lethargy, seizures) - Rapid weight gain due to fluid overload - Allergic reactions (rash, swelling, difficulty breathing) If any of these occur, obtain urgent medical attention. ### Drug & Food Interactions - **Diuretics (especially thiazides)** - may increase the risk of hyponatremia. - **Non-steroidal anti-inflammatory drugs (NSAIDs)** - can potentiate water retention. - **Selective serotonin reuptake inhibitors (SSRIs)** - reported cases of additive hyponatremia. - **Alcohol** - enhances the antidiuretic effect, increasing the chance of water intoxication. Discuss all current medications, including over-the-counter products and supplements, with your healthcare provider before initiating Nocdurna. ## Off-Label and Investigational Uses of Nocdurna - **Nocturnal Polyuria in Adults** Clinical observations suggest that low-dose desmopressin can reduce nighttime urine volume in adults with overactive bladder or age-related polyuria. Evidence is limited to small cohort studies, and regulatory approval is lacking. - **Adjunctive Hemostatic Agent in Cardiac Surgery** Some centers have used desmopressin to mitigate bleeding in patients receiving antiplatelet therapy. Randomized trials are ongoing, and the practice remains off-label. - **Management of Certain Types of Hyponatremia** In rare cases, desmopressin is employed to stabilize serum sodium levels during the correction of severe hyponatremia, preventing rapid fluctuations. This use is guided by specialist protocols. All off-label applications should be undertaken only under close supervision of a qualified healthcare professional. ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F) in a dry place, protected from light and moisture. - Keep the container tightly closed; do not refrigerate unless instructed by a pharmacist. - Dispose of any unused tablets by returning them to a pharmacy take-back program or following local hazardous-waste regulations. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Nocdurna?** Yes, but keep the medication in its original packaging with a copy of the prescription (or a physician’s letter) to satisfy customs regulations in most countries. - **Should I avoid certain foods while taking Nocdurna?** Plain water is recommended; excessive intake of salty foods or large quantities of fluid can counteract the drug’s antidiuretic effect and increase the risk of hyponatremia. - **Is it safe to drink alcohol on days I take Nocdurna?** Alcohol can amplify water retention, so moderate consumption is advised, and you should monitor for signs of dizziness or confusion. **Product & Formulation Details** - **What do Nocdurna tablets look like?** The tablets are white, round, film-coated, and scored for possible splitting. Identifying marks may vary by manufacturer, but the imprint typically reads “NOC 0.2”. - **Can the tablet be split?** Yes, the tablet is scored and can be halved if a lower dose is clinically indicated, though this should only be done under professional guidance. - **Are there any inactive ingredients I should be aware of?** Common excipients include lactose, microcrystalline cellulose, and magnesium stearate. Patients with lactose intolerance should discuss alternatives with their pharmacist. **Regulatory & Safety Nuances** - **Will Nocdurna show up on a sports drug test?** Desmopressin is not listed as a prohibited substance by major sporting bodies, but athletes should disclose its use to ensure compliance with any therapeutic-use exemption policies. - **Is Nocdurna approved for use in pregnancy?** Desmopressin is classified as Category B (no evidence of risk in animal studies, but human data are limited). It should only be used during pregnancy when clearly needed and prescribed by a physician. - **What is the legal status of importing Nocdurna for personal use?** Personal importation of a prescription medication is permitted in many jurisdictions when the quantity is for a 90-day supply and a valid prescription is provided. Local regulations may vary, so verify with your national health authority. **Scientific & Clinical Curiosity** - **When was desmopressin first introduced to the market?** Desmopressin was approved by the FDA in 1978 for the treatment of diabetes insipidus and later gained additional indications such as nocturnal enuresis. - **How does Nocdurna compare to intranasal desmopressin?** Oral tablets offer more convenient dosing and a longer duration of action, whereas intranasal formulations provide a quicker onset but may be associated with higher rates of nasal irritation. Bioavailability of the oral tablet is approximately 15 %-20 % of the intranasal route. - **Are there any known drug-resistance issues with desmopressin?** Tolerance can develop with prolonged high-dose use, particularly in patients with chronic hyponatremia risk. Periodic evaluation of serum sodium and dose adjustments help mitigate this concern. ## Glossary **Antidiuretic Hormone (ADH)** : A hormone produced by the posterior pituitary that promotes water reabsorption in the kidneys, regulating urine concentration. **V2 Receptor** : A specific receptor subtype located in renal collecting-duct cells; activation triggers water channel insertion and antidiuretic effects. **Hyponatremia** : A condition characterized by abnormally low serum sodium concentration, which can lead to neurological symptoms if severe. **Bioavailability** : The proportion of an administered dose that reaches systemic circulation in an active form. **Factor VIII** : A clotting protein essential for the coagulation cascade; deficiency leads to hemophilia A. ## Disclaimer The information presented about Nocdurna is intended for general educational purposes and does not substitute professional medical counsel. Treatment choices, including any off-label applications, should be made under the direct oversight of a qualified healthcare practitioner. Readers are presumed to be competent adults capable of making informed health decisions. Our pharmacy service makes Nocdurna accessible to individuals who may encounter limited availability through conventional channels or who are seeking cost-effective generic alternatives. Prior to initiating, altering, or discontinuing therapy, always consult your physician or pharmacist.